|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Bilcare Global Clinical Supplies (Europe) Ltd. Forms Corporate Advisory Board; Inducts Former Pfizer Inc. (PFE) President and the Executive Director of Waterloo Institute of Nanotechnology as Members
4/30/2008 10:36:40 AM
PHOENIXVILLE, PA--(Marketwire - April 30, 2008) - Bilcare Global Clinical Supplies, a leading single-source provider of clinical trial services, has formed its first corporate Advisory Board. Bilcare Limited's Chairman and Managing Director Mohan Bhandari announced former Pfizer President John LaMattina, Ph.D., and Waterloo Institute of Nanotechnology Executive Director Arthur Carty, Ph.D., D.Sc., as the board's inaugural members. Dr. LaMattina will serve as its Chairman. The advisory board was created to provide the Bilcare GCS Senior Management Team with independent scientific industry expertise and insight to assist in the accomplishment of scientific and business objectives in support of the company's global mission. "The formation of our corporate Advisory Board is another major milestone in our mission to make Bilcare GCS the global leader in the clinical trial supplies arena," said Bhandari. "The addition of these accomplished members will prove to be a tremendous asset to research and innovation initiatives of our company."
|
|
|
|
|
|
|
|
|
|
|